NCT06258642 2025-08-20Irinotecan Liposome Combined With Anlotinib as Second-line Regimen for SCLCFudan UniversityPhase NA Recruiting39 enrolled
NCT07004712 2025-06-08Efficacy and Biomarkers of the Second-line Treatment of Adebelizumab Combined With Irinotecan Liposome in Advanced Small Cell Lung CancerPeking University Cancer Hospital & InstitutePhase 2 Not yet recruiting46 enrolled